Skip to main content
. 2018 Oct 31;10:5209–5218. doi: 10.2147/CMAR.S175961

Table 7.

Distributions of the three SNPs and alleles in two groups and their relationship with susceptibility of squamous lung cancer

SNP Squamous lung cancer
Controls, n (%) Cases, n (%) ORa (95% CI) Pb

rs920778
TT 324 (59.7) 76 (58) 1.00 (ref)
TC 197 (36.3) 51 (38.9) 1.165 (0.785–1.730) 0.449
CC 22 (4.1) 4 (3.1) 0.751 (0.250–2.250) 0.609
TC+CC vs TT 1.122 (0.762–1.650) 0.560
CC vs TT+TC 0.707 (0.239–2.095) 0.532
T allele 845 (77.8) 203 (77.5) 1.00 (ref) 0.909
C allele 241 (22.2) 59 (22.5) 1.019 (0.738–1.408)
rs12826786
CC 340 (62.6) 91 (69.5) 1.00 (ref)
CT 185 (34.1) 38 (29.0) 0.786 (0.516–1.198) 0.262
TT 18 (3.3) 2 (1.5) 0.406 (0.092–1.790) 0.234
CT+TT vs CC 0.751 (0.497–1.135) 0.174
TT vs CC+CT 0.439 (0.100–1.923) 0.275
C allele 865 (79.7) 220 (84.0) 1.00 (ref) 0.113
T allele 221 (20.3) 42 (16.0) 0.747 (0.520–1.073)
rs4759314
AA 526 (96.9) 114 (86.9) 1.00 (ref)
AG 16 (2.9) 17 (13.1) 4.671 (2.279–9.572) <0.001*
GG 1 (0.2) 0 (0.0)
GG+AG vs AA 4.614 (2.286–9.311) <0.001*
GG vs AA+AG
A allele 1,068 (98.3) 245 (93.5) 1.00(ref) <0.001*
G allele 18 (1.7) 17 (6.5) 4.117 (2.092–8.104)

Notes:

a

OR adjusted for age;

b

P-value adjusted for age;

*

Indicates statistical significance (P<0.05); – indicates the results cannot be calculated.

Abbreviations: ref, reference; SNP, single nucleotide polymorphism.